A new way to grow T cells in the lab enables them to live longer and better destroy cancer cells in a mouse model of melanoma compared to those grown in traditional growth media. The findings have the potential to greatly improve the effectiveness of cancer immunotherapies that involve taking T cells from a patient and growing them to enormous numbers in the lab before reinfusing them back into the body.

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, according to a new study published in Advanced Functional Materials. The breakthrough centers on a new class of materials called lipopeptide hydrogels (LPHs), which show promise in boosting immune responses and possess adjuvant-like properties.

West Virginia University microbiologists have identified an antibody that can kill one of the most drug-resistant bacteria. Now, supported by a $3.5 million grant from the National Institute of Allergy and Infectious Diseases, they want to determine whether it can be combined with other antibiotics to produce a potent treatment against infection.

A new study published in Nature Communications shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood cancers.

A new class of lipids developed by Penn Engineers improve the rates at which lipid nanoparticles (LNPs) successfully deliver RNA therapeutics and gene editing tools, promising to increase their effectiveness of such treatments.